Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Statistics
Share Statistics
Beam Therapeutics has 100.56M shares outstanding. The number of shares has increased by 21.3% in one year.
| 100.56M |
| 21.3% |
| 20.57% |
| 98.87% |
| n/a |
| 57,864 |
| 2.41% |
Short Selling Information
The latest short interest is 20.84M, so 20.73% of the outstanding shares have been sold short.
| 20.84M |
| 20.73% |
| 23.31% |
| 9.09 |
Valuation Ratios
The PE ratio is -5.42 and the forward PE ratio is -3.61. Beam Therapeutics's PEG ratio is -0.03.
| -5.42 |
| -3.61 |
| 32.14 |
| 3.9 |
| 2.78 |
| -5.73 |
| -0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Beam Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 4.82, with a Debt / Equity ratio of 0.22.
| 4.82 |
| 4.82 |
| 0.22 |
| -0.42 |
| -0.45 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $161,623.41 |
| $-958,631.04 |
| 393 |
| 0.06 |
| n/a |
Taxes
| 39K |
| -0.01% |
Stock Price Statistics
The stock price has increased by -20.08% in the last 52 weeks. The beta is 2.08, so Beam Therapeutics's price volatility has been higher than the market average.
| 2.08 |
| -20.08% |
| 17.73 |
| 23.78 |
| 56.95 |
| 2,397,538 |
Income Statement
In the last 12 months, Beam Therapeutics had revenue of 63.52M and earned -376.74M in profits. Earnings per share was -4.58.
| 63.52M |
| 41.59M |
| -415.57M |
| -376.74M |
| -383.98M |
| -415.57M |
| -4.58 |
Balance Sheet
The company has 281.97M in cash and 161.43M in debt, giving a net cash position of 120.54M.
| 281.97M |
| 161.43M |
| 120.54M |
| -1.57B |
| 1.47B |
| 1.11B |
Cash Flow
In the last 12 months, operating cash flow was -347.25M and capital expenditures -8.95M, giving a free cash flow of -356.19M.
| -347.25M |
| -8.95M |
| -356.19M |
| -4.33 |
Margins
Gross margin is 65.48%, with operating and profit margins of -654.25% and -593.13%.
| 65.48% |
| -654.25% |
| -593.06% |
| -593.13% |
| -604.51% |
| -654.25% |
| -560.77% |
Dividends & Yields
BEAM pays an annual dividend of $1.12, which amounts to a dividend yield of 4.8%.
| $1.12 |
| 4.8% |
| 0% |
| -24.4% |
| n/a |
| n/a |
Analyst Forecast
The average price target for BEAM is $42, which is 126.4% higher than the current price. The consensus rating is "Buy".
| $42 |
| 126.4% |
| Buy |
| 12 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 1.34 |
| 3 |